AstraZeneca : AZN

All AstraZeneca Articles

222 Articles

Jon C. Ogg | Feb 4, 2011 at 12:17 PM EST

2011 Stock Buybacks on Fire, Over $34 Billion (PFE, UNP, GME, ERTS, GD, TUP, MHS, VZ, UNM, MO, AZN, SYMC, YUM, DGX, COH, TIF, INTC)

The method of using capital from the corporate treasury to return capital to shareholders via share repurchase programs has long…

Jon C. Ogg | Dec 7, 2010 at 8:08 AM EST

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc.…

Jon C. Ogg | Sep 29, 2010 at 7:44 AM EDT

Top Analyst Upgrades and Downgrades (AMAT, AZN, BSX, CCL, ENDP, JCG, KLAC, LRCX, LVS, MDT, MPEL, MGM, NVLS, PENN, DGX, TKC, WYNN)

These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research notes: Applied Materials…

Jon C. Ogg | Sep 23, 2010 at 8:19 AM EDT

Top Analyst Upgrades and Downgrades (MO, AGU, AZN, ATHN, BRCD, DD, GSK, INAP, LO, MMYT, MOS, NBG, NVDA, POT)

There are many research calls this Thursday morning and these are just some of the top analyst upgrades, downgrades, and…

Jon C. Ogg | Jun 30, 2010 at 8:01 AM EDT

Top Analyst Upgrades and Downgrades (AZN, EXFO, FTE, HCBK, LPX, PT, SNN, USB, VOD)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research early this Wednesday. Some…

Jon C. Ogg | May 29, 2010 at 10:34 AM EDT

The Unusual Suspects (AIG, AZN, BRK-A, BRK-B, MCO, C, GNMK, IEP, LGF, SI, STP, PHYS, SNF, EWP, TEF)

We have an unusual cast of characters in this week’s version of THE UNUSUAL SUSPECTS for the week ahead, with…

Douglas A. McIntyre | May 19, 2010 at 8:10 PM EDT

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

The pharmaceutical industry has found a growing source of sales–the prescription of medicines, primarily used by adults in the past,…

Douglas A. McIntyre | Nov 17, 2009 at 11:37 AM EST

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once…

Douglas A. McIntyre | Aug 20, 2009 at 7:48 AM EDT

Top 10 Analyst Upgrades & Downgrades (AZN, BDN, CHA, HURN, PRU, PETM, RF, SOL, RDS-B, TWB, UA)

These are Thursday’s top ten analyst research summary upgrades, downgrades, and initiations from Wall Street brokerage firms: AstraZeneca (AZN) Cut…

Douglas A. McIntyre | Aug 10, 2009 at 10:56 AM EDT

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so…

Douglas A. McIntyre | Jul 30, 2009 at 3:28 PM EDT

Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)

You can just see the TV advertisements now… Wal-Mart and Uncle Sam are “rolling back” swine flu. The retailer is…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

Douglas A. McIntyre | Jun 25, 2009 at 11:31 AM EDT

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early…

Douglas A. McIntyre | May 14, 2009 at 6:24 AM EDT

Top 10 Analyst Upgrades & Downgrades (AZN, BAS, BRNC, BCS, DB, PCS, MYL, PTEN, PDC, WSH)

These are the top 10 early bird analyst upgrades and downgrades we have seen in Wall Street research calls early…

Douglas A. McIntyre | Apr 27, 2009 at 6:54 AM EDT

Top Analyst Upgrades (AZN, BMR, ETR, MMM, NFLX, NVO, SWK)

These are some of the top pre-market analyst upgrades we have seen from Wall Street early this Monday morning: AstraZeneca…

1 … 12 13 14 15

AstraZeneca : AZN

All AstraZeneca Articles

2011 Stock Buybacks on Fire, Over $34 Billion (PFE, UNP, GME, ERTS, GD, TUP, MHS, VZ, UNM, MO, AZN, SYMC, YUM, DGX, COH, TIF, INTC)

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

Top Analyst Upgrades and Downgrades (AMAT, AZN, BSX, CCL, ENDP, JCG, KLAC, LRCX, LVS, MDT, MPEL, MGM, NVLS, PENN, DGX, TKC, WYNN)

Top Analyst Upgrades and Downgrades (MO, AGU, AZN, ATHN, BRCD, DD, GSK, INAP, LO, MMYT, MOS, NBG, NVDA, POT)

Top Analyst Upgrades and Downgrades (AZN, EXFO, FTE, HCBK, LPX, PT, SNN, USB, VOD)

The Unusual Suspects (AIG, AZN, BRK-A, BRK-B, MCO, C, GNMK, IEP, LGF, SI, STP, PHYS, SNF, EWP, TEF)

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

Top 10 Analyst Upgrades & Downgrades (AZN, BDN, CHA, HURN, PRU, PETM, RF, SOL, RDS-B, TWB, UA)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Top 10 Analyst Upgrades & Downgrades (AZN, BAS, BRNC, BCS, DB, PCS, MYL, PTEN, PDC, WSH)

Top Analyst Upgrades (AZN, BMR, ETR, MMM, NFLX, NVO, SWK)

Suze Orman Slams ‘Bad Advice’ on Social Security and Urges Retirees to Maximize Their Payout

Here’s How You Can Retire to a Greek Island at 62 on Social Security and a Small Pension

The Dividend Growth Path That Turns $500,000 Into a Six-Figure Income Stream

Suze Orman Slams 'Bad Advice' on Social Security and Urges Retirees to Maximize Their Payout

Here's How You Can Retire to a Greek Island at 62 on Social Security and a Small Pension

Suze Orman Slams ‘Bad Advice’ on Social Security and Urges Retirees to Maximize Their Payout

Here’s How You Can Retire to a Greek Island at 62 on Social Security and a Small Pension

AstraZeneca : AZN

All AstraZeneca Articles

2011 Stock Buybacks on Fire, Over $34 Billion (PFE, UNP, GME, ERTS, GD, TUP, MHS, VZ, UNM, MO, AZN, SYMC, YUM, DGX, COH, TIF, INTC)

Top Analyst Upgrades and Downgrades (AMGN, AZN, BIIB, CELG, GSK, GFI, HGSI, LDK, MWV, NVS, RHT, RIMM, STX, SFD, STP, TIN, TSL, WDC)

Top Analyst Upgrades and Downgrades (AMAT, AZN, BSX, CCL, ENDP, JCG, KLAC, LRCX, LVS, MDT, MPEL, MGM, NVLS, PENN, DGX, TKC, WYNN)

Top Analyst Upgrades and Downgrades (MO, AGU, AZN, ATHN, BRCD, DD, GSK, INAP, LO, MMYT, MOS, NBG, NVDA, POT)

Top Analyst Upgrades and Downgrades (AZN, EXFO, FTE, HCBK, LPX, PT, SNN, USB, VOD)

The Unusual Suspects (AIG, AZN, BRK-A, BRK-B, MCO, C, GNMK, IEP, LGF, SI, STP, PHYS, SNF, EWP, TEF)

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

Top 10 Analyst Upgrades & Downgrades (AZN, BDN, CHA, HURN, PRU, PETM, RF, SOL, RDS-B, TWB, UA)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Top 10 Analyst Upgrades & Downgrades (AZN, BAS, BRNC, BCS, DB, PCS, MYL, PTEN, PDC, WSH)

Top Analyst Upgrades (AZN, BMR, ETR, MMM, NFLX, NVO, SWK)

Suze Orman Slams ‘Bad Advice’ on Social Security and Urges Retirees to Maximize Their Payout

Here’s How You Can Retire to a Greek Island at 62 on Social Security and a Small Pension

The Dividend Growth Path That Turns $500,000 Into a Six-Figure Income Stream

Featured Reads

Suze Orman Slams 'Bad Advice' on Social Security and Urges Retirees to Maximize Their Payout

Here's How You Can Retire to a Greek Island at 62 on Social Security and a Small Pension